01

Jun

GSK buys US Vaccine Firm for $3.3bn

GlaxoSmithKline on Tuesday bought Affinivax, a US biopharmaceutical firm for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm. The London-listed company has agreed to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones for Affinivax. According to GSK, “the proposed acquisition further strengthens our vaccines […]

Read Article

01

Jun

Stock market declines by 1.45% on profit taking

It was yet another bearish session on the floor of the Nigerian stock market on Tuesday as profit taking by investors dragged the market down further The All Share Index dropped by 1.45% to close at 52,990.28 points from the previous close of 53,772.14 points. The Market Capitalisation declined by 1.45% to close at N28.568 trillion from[…]

Read Article

31

May

Flour Mills reports N1.16trn as turnover, PAT rises by 8.94%

Flour Mills of Nigeria on Monday published its Audited Financial Statement for the year ended 31 March 2022. The Company reported a turnover of N1.164 trillion for the 12 months period, up by 50.83% from N771.6 billion reported the previous year. Profit after tax grew year on year by 8.94% to N28.015 billion from N25.717 billion reported[…]

Read Article